mHealth program to help manage pain after cancer treatment
PsyMINT: Mobile Health (mHealth) Intervention to Support Self-Management of Pain and Symptoms for Cancer Survivors
NA · Virginia Commonwealth University · NCT07332377
This one-week beta test will try a mobile app that sends brief messages and short surveys to help post-treatment cancer survivors manage pain and other symptoms.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Virginia Commonwealth University (other) |
| Locations | 1 site (Richmond, Virginia) |
| Trial ID | NCT07332377 on ClinicalTrials.gov |
What this trial studies
This is a single-arm feasibility pilot of the PsyMINT beta mobile app for post-treatment cancer survivors who report pain. Participants will receive a one-week intervention consisting of brief intervention messages, ecological momentary assessments (EMAs), and e-diary entries delivered through the app. Messages are organized into five modules covering pain education, positive psychology, opioid literacy, communication skills with providers, and quality of life. The study will measure the practicality of using the app as a message-delivery platform and collect preliminary data on self-efficacy and symptom self-management to inform a future randomized trial.
Who should consider this trial
Good fit: Adults (≥18) who are cancer survivors in complete remission within the past three years, currently experiencing cancer- or treatment-related pain, and able to read English and use an online/mobile app are the intended participants.
Not a fit: People who are taking psychiatric medications, have major psychotic or substance use disorders, are pregnant or planning pregnancy in the next three months, or who cannot use an English-language smartphone app are unlikely to benefit from this pilot.
Why it matters
Potential benefit: If successful, the app could help survivors feel more confident managing pain and reduce symptom burden using nonpharmacologic strategies.
How similar studies have performed: Previous mHealth and behavioral interventions for cancer-related symptoms have shown promise in small studies, but this specific PsyMINT app and its one-week beta format are novel and require feasibility testing.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * In a post-treatment stage with no evidence of disease (complete remission) * Diagnosed with cancer in the past three years * Experiencing cancer/treatment-related pain * ≥ 18 years of age at the time of first diagnosis * Cognitively able to actively participate in an online-based study * Able to read, write, and understand English Exclusion Criteria: * Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers) * Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders. * Those who are currently pregnant or plan to become pregnant in the next three months
Where this trial is running
Richmond, Virginia
- Virginia Commonwealth University — Richmond, Virginia, United States (RECRUITING)
Study contacts
- Principal investigator: Sun Jung Kim, Ph.D — Virginia Commonwealth University
- Study coordinator: Sun Jung Kim, Ph.D
- Email: sjkim2@vcu.edu
- Phone: 804-628-4688
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pain, Pain Management, Symptom Monitoring, Symptom Management, Cancer Survivorship, cancer survivorship, pain management, mHealth